Concepts (68)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Endometriosis | 5 | 2024 | 186 | 1.830 |
Why?
|
| Endometrium | 4 | 2024 | 289 | 1.090 |
Why?
|
| Uterus | 3 | 2024 | 587 | 0.940 |
Why?
|
| Oogenesis | 1 | 2025 | 57 | 0.930 |
Why?
|
| Sumoylation | 1 | 2025 | 40 | 0.920 |
Why?
|
| Ovarian Follicle | 1 | 2025 | 125 | 0.880 |
Why?
|
| Oocytes | 2 | 2025 | 302 | 0.850 |
Why?
|
| Infertility | 1 | 2024 | 82 | 0.800 |
Why?
|
| RNA | 3 | 2021 | 607 | 0.790 |
Why?
|
| Enhancer Elements, Genetic | 2 | 2021 | 322 | 0.620 |
Why?
|
| Pregnancy Complications | 1 | 2024 | 553 | 0.600 |
Why?
|
| Transcription, Genetic | 1 | 2020 | 1761 | 0.450 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2024 | 610 | 0.320 |
Why?
|
| Cell Cycle Proteins | 2 | 2023 | 709 | 0.290 |
Why?
|
| Ubiquitin-Conjugating Enzymes | 1 | 2025 | 42 | 0.230 |
Why?
|
| Activin Receptors, Type I | 1 | 2024 | 36 | 0.230 |
Why?
|
| Signal Transduction | 4 | 2024 | 4934 | 0.220 |
Why?
|
| Smad5 Protein | 1 | 2024 | 22 | 0.220 |
Why?
|
| Aminopyridines | 1 | 2024 | 60 | 0.210 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2024 | 130 | 0.200 |
Why?
|
| Decidua | 1 | 2024 | 142 | 0.200 |
Why?
|
| Smad Proteins | 1 | 2023 | 43 | 0.200 |
Why?
|
| Li-Fraumeni Syndrome | 1 | 2023 | 52 | 0.200 |
Why?
|
| Pregnancy | 3 | 2024 | 7570 | 0.200 |
Why?
|
| Animals | 7 | 2025 | 36557 | 0.200 |
Why?
|
| Mice | 6 | 2025 | 19055 | 0.190 |
Why?
|
| Receptors, Steroid | 1 | 2024 | 276 | 0.190 |
Why?
|
| Pyrroles | 1 | 2024 | 187 | 0.190 |
Why?
|
| Embryo Implantation | 1 | 2024 | 235 | 0.190 |
Why?
|
| Female | 10 | 2025 | 71928 | 0.180 |
Why?
|
| Protein Kinases | 1 | 2023 | 345 | 0.180 |
Why?
|
| Long Interspersed Nucleotide Elements | 1 | 2021 | 37 | 0.180 |
Why?
|
| RNA Splicing Factors | 1 | 2021 | 55 | 0.180 |
Why?
|
| Transforming Growth Factor beta | 1 | 2024 | 488 | 0.180 |
Why?
|
| Adenosine | 1 | 2021 | 140 | 0.170 |
Why?
|
| Neoplasm Proteins | 1 | 2024 | 719 | 0.160 |
Why?
|
| Glioma | 1 | 2023 | 540 | 0.140 |
Why?
|
| Humans | 12 | 2024 | 134156 | 0.130 |
Why?
|
| Mice, Knockout | 1 | 2025 | 4016 | 0.130 |
Why?
|
| Nerve Tissue Proteins | 1 | 2021 | 1167 | 0.120 |
Why?
|
| Small Molecule Libraries | 2 | 2024 | 138 | 0.100 |
Why?
|
| Epithelium | 2 | 2023 | 366 | 0.090 |
Why?
|
| Transcription Factors | 1 | 2021 | 2738 | 0.090 |
Why?
|
| Estrogens | 2 | 2024 | 525 | 0.090 |
Why?
|
| DNA | 2 | 2024 | 1682 | 0.070 |
Why?
|
| Activin Receptors, Type II | 1 | 2024 | 33 | 0.060 |
Why?
|
| Receptors, Eph Family | 1 | 2024 | 22 | 0.060 |
Why?
|
| Receptor, EphA2 | 1 | 2024 | 29 | 0.060 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2024 | 148 | 0.050 |
Why?
|
| Drug Discovery | 1 | 2024 | 179 | 0.050 |
Why?
|
| Proteoglycans | 1 | 2023 | 94 | 0.050 |
Why?
|
| Steroids | 1 | 2024 | 213 | 0.050 |
Why?
|
| Gene Expression Regulation | 2 | 2021 | 2669 | 0.050 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2023 | 235 | 0.050 |
Why?
|
| Regulatory Elements, Transcriptional | 1 | 2021 | 33 | 0.050 |
Why?
|
| Cell Survival | 1 | 2024 | 890 | 0.040 |
Why?
|
| Progesterone | 1 | 2024 | 635 | 0.040 |
Why?
|
| Fertility | 1 | 2023 | 270 | 0.040 |
Why?
|
| Methylation | 1 | 2021 | 232 | 0.040 |
Why?
|
| Cell Movement | 1 | 2024 | 920 | 0.040 |
Why?
|
| Receptors, Progesterone | 1 | 2024 | 898 | 0.040 |
Why?
|
| Organoids | 1 | 2023 | 299 | 0.040 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2023 | 645 | 0.040 |
Why?
|
| Transcriptional Activation | 1 | 2021 | 504 | 0.040 |
Why?
|
| Homeostasis | 1 | 2023 | 751 | 0.040 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2023 | 797 | 0.040 |
Why?
|
| Cell Differentiation | 1 | 2023 | 2045 | 0.030 |
Why?
|
| Genome, Human | 1 | 2021 | 1351 | 0.030 |
Why?
|